Dr. Jason Lickliter heads Nucleus Network’s Medical Department; this includes a multi-site team of Medical Officers. Jason has extensive experience across all aspects of early phase clinical trials from protocol design and implementation to the integration of Biomarker studies and advanced imaging into clinical research. With a Medical Oncology and Clinical Hematology background, his achievements include the establishment of a Phase 1 Cancer Trials Program at Monash Medical Centre.
- Forums
- ASX - By Stock
- Ann: Amplia Appoints Dr Jason Lickliter as Chief Medical Officer
ATX
amplia therapeutics limited
Add to My Watchlist
2.13%
!
24.0¢

Dr. Jason Lickliter heads Nucleus Network’s Medical Department;...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
24.0¢ |
Change
0.005(2.13%) |
Mkt cap ! $116.7M |
Open | High | Low | Value | Volume |
24.0¢ | 24.5¢ | 22.5¢ | $2.020M | 8.588M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 230225 | 23.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 778184 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 230225 | 0.235 |
10 | 1258647 | 0.230 |
15 | 758333 | 0.225 |
19 | 540605 | 0.220 |
3 | 287558 | 0.215 |
Price($) | Vol. | No. |
---|---|---|
0.240 | 778184 | 1 |
0.245 | 305000 | 5 |
0.250 | 145520 | 6 |
0.255 | 160816 | 3 |
0.260 | 117000 | 4 |
Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
Featured News
ATX (ASX) Chart |